IMvigor011: a Study of Adjuvant Atezolizumab in Patients with High-Risk MIBC Who Are Ctdna+ Post-Surgery.
FUTURE ONCOLOGY（2023）
Key words
adjuvant therapy,atezolizumab,biomarkers,bladder cancer,ctDNA,immune checkpoint inhibitors,upper tract tumors,urothelial carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined